| 摘要 |
FIELD: chemistry. ^ SUBSTANCE: invention concerns crystal habits of fluvastatin sodium salt hydrates referred to as polymorphic crystal habits C, D, E and F. Production method of these crystal habits, pharmaceutical composition for 3-hydroxy-3-methylglutaryl- coenzyme YMG-CoA inhibition based on these crystal habits C, D, E, F are described. ^ EFFECT: production of crystal habits of fluvastatin sodium salt hydrates. ^ 8 cl, 6 dwg, 6 ex |
